Ditchcarbon
  • Contact
  1. Organizations
  2. Corium, LLC
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 months ago

Corium, LLC Sustainability Profile

Company website

Corium, LLC, headquartered in the United States, is a leading innovator in the pharmaceutical industry, specialising in advanced drug delivery systems. Founded in 2010, the company has made significant strides in developing unique transdermal and microneedle technologies that enhance patient compliance and therapeutic efficacy. With a focus on transforming the way medications are administered, Corium's core products include its proprietary transdermal patches and microneedle arrays, which stand out for their precision and effectiveness. The company operates primarily in North America, with a growing presence in international markets. Recognised for its commitment to quality and innovation, Corium has achieved notable milestones, including strategic partnerships with major pharmaceutical firms. This positions Corium, LLC as a key player in the evolving landscape of drug delivery solutions, dedicated to improving patient outcomes through cutting-edge technology.

DitchCarbon Score

How does Corium, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

26

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Corium, LLC's score of 26 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.

42%

Let us know if this data was useful to you

Corium, LLC's reported carbon emissions

In 2023, Corium, LLC reported total carbon emissions of approximately 12,297,884 kg CO2e. The breakdown of these emissions includes Scope 1 emissions at about 19,643,000 kg CO2e, Scope 2 emissions at approximately 45,485,000 kg CO2e, and Scope 3 emissions at around 15,904 kg CO2e. Within Scope 3, significant contributors include upstream transportation and distribution at about 9,330,593 kg CO2e and fuel and energy-related activities at approximately 1,940,296 kg CO2e. Despite the substantial emissions figures, Corium, LLC has not disclosed any specific reduction targets or initiatives as part of their climate commitments. There are no emissions data from previous years available for comparison, and the company does not appear to inherit any emissions data from a parent organisation. Overall, while Corium, LLC has provided detailed emissions data for 2023, their climate strategy and reduction commitments remain unspecified, indicating a potential area for future development in their sustainability efforts.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2023
Scope 1
19,643,000
Scope 2
45,485,000
Scope 3
15,903.67

How Carbon Intensive is Corium, LLC's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Corium, LLC's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Corium, LLC's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Corium, LLC is in US, which has a low grid carbon intensity relative to other regions.

Corium, LLC's Scope 3 Categories Breakdown

Their carbon footprint includes supplier sustainability and value chain emissions data across Scope 3 categories, with "Upstream Transportation & Distribution" being the largest emissions source at 58669% of Scope 3 emissions.

Top Scope 3 Categories

2023
Upstream Transportation & Distribution
58669%
Fuel and Energy Related Activities
12200%
Capital Goods
3191%
Business Travel
1929%
Purchased Goods and Services
978%
Employee Commuting
359%

Corium, LLC's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Corium, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Corium, LLC's Emissions with Industry Peers

Cumberland Pharmaceuticals Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Abbvie

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

DMK Pharmaceuticals Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Zevra Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

DURECT Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Shionogi

JP
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251106.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy